World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 30

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5576)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-3) series.

Item

Count

PDF

140

HTML

3492

Tables (1-3)

370

Sum=4002

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

211

Download

449

Sum=660

Publishing Process of This Article

Item

Count

Browse

169

Download

543

Sum=712

Aug 14, 2024 (publication date) through Nov 2, 2025

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Soresi M, Giannitrapani L. Glucagon-like peptide 1 agonists are potentially useful drugs for treating metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2024; 30(30): 3541-3547 [PMID: 39193573 DOI: 10.3748/wjg.v30.i30.3541]
URL:	https://www.wjgnet.com/1007-9327/full/v30/i30/3541.htm

Number	Citing Articles
1	Anmol Singh, Aalam Sohal, Akash Batta. GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis. World Journal of Gastroenterology 2024; 30(48): 5205-5211 doi: 10.3748/wjg.v30.i48.5205 Abstract(655) \| Core Tip(595) \| Full Article(HTML)(5946) \| Full Article with Cover (PDF)-608K(176) \| Audio-1042K(9) \| Peer-Review Report-296K(77) \| Answering Reviewers-198K(84) \| Full Article (PDF)-395K(330) \| Full Article (XML)-98K(94) \| Times Cited (19) \| Total Visits (9215) \| Open
2	Bryan A. Priego-Parra, Rocío Gallego-Durán, Berenice M. Román-Calleja, José Antonio Velarde-Ruiz Velasco, Manuel Romero-Gómez, Jordi Gracia-Sancho. Advancing precision medicine in metabolic dysfunction-associated steatotic liver disease. Trends in Endocrinology & Metabolism 2025; doi: 10.1016/j.tem.2025.03.006
3	Adrián Cortés-Martín, Julio Plaza-Diaz. Exploring the therapeutic potential of glucagon-like peptide 1 agonists in metabolic disorders. World Journal of Gastroenterology 2025; 31(4): 101436 doi: 10.3748/wjg.v31.i4.101436 Abstract(455) \| Core Tip(471) \| Full Article(HTML)(1736) \| Full Article with Cover (PDF)-724K(98) \| Audio-1235K(4) \| Peer-Review Report-175K(72) \| Answering Reviewers-97K(78) \| Full Article (PDF)-409K(113) \| Full Article (XML)-106K(77) \| Times Cited (0) \| Total Visits (3883) \| Open
4	Jan Škrha. Liver steatosis and Type 2 diabetes mellitus. Vnitřní lékařství 2025; 71(3): 170 doi: 10.36290/vnl.2025.030
5	Yilmaz Gunes. A brief approach to hypertension in type 2 diabetes mellitus. Exploration of Endocrine and Metabolic Diseases 2025; doi: 10.37349/eemd.2025.101422
6	Alfredo Vozza, Domenico Triggiani, Margherita Fanelli, Giuseppe Lisco, Deborah Coletto, Carlo Custodero, Sara Volpe, Davide Racaniello, Valentina Colaianni, Valentina Lavarra, Rosselia Maggipinto, Andrea Portacci, Cosimo Tortorella, Antonio Moschetta, Giuseppina Piazzolla. Predictive factors of body weight loss in patients with type 2 diabetes treated with GLP-1 receptor agonists: a 52-week prospective real-life study. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1674308
7	Shujun Li, Nanqu Huang, Mei Wang, Wendi Huang, Yong Luo, Juan Huang. GLP-1R in diabetes mellitus: from basic discovery to therapeutics development. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1610512
8	Mo-Wei Kong, Yang Yu, Ying Wan, Yu Gao, Chun-Xiang Zhang. Glucagon-like peptide-1 receptor agonists: Exploring the mechanisms from glycemic control to treatment of multisystemic diseases. World Journal of Gastroenterology 2024; 30(36): 4036-4043 doi: 10.3748/wjg.v30.i36.4036 Abstract(543) \| Core Tip(554) \| Full Article(HTML)(3802) \| Full Article with Cover (PDF)-3832K(97) \| Audio-2895K(19) \| Peer-Review Report-220K(81) \| Answering Reviewers-42K(88) \| Full Article (PDF)-3417K(172) \| Full Article (XML)-95K(94) \| Times Cited (0) \| Total Visits (7628) \| Open
9	Piotr Olejnik, Kaja Kasarełło, Renata Podkowińska-Polak, Aleksandra Golenia. Psoriasis: an emerging risk factor for ischemic stroke?. Frontiers in Neurology 2025; 16 doi: 10.3389/fneur.2025.1599978
10	Junyu Wang, Jingting Lei, Martin C. Harmsen, Han Moshage. From cooperation to collapse: systemic failure in liver disease through a sociological lens. Exploration of Digestive Diseases 2025; 4 doi: 10.37349/edd.2025.100580
11	Jheng-Yan Wu, Wan-Hsuan Hsu, Chia-Chih Kuo, Ya-Wen Tsai, Ting-Hui Liu, Po-Yu Huang, Min-Hsiang Chuang, Kuo-Chuan Hung, Tsung Yu, Chih-Cheng Lai. A retrospective analysis of combination therapy with GLP-1 receptor agonists and SGLT2 inhibitors versus SGLT2 inhibitor monotherapy in patients with MASLD. Nature Communications 2025; 16(1) doi: 10.1038/s41467-025-62891-8
12	Weixin Wang, Xin Gao, Wentong Niu, Jinping Yin, Kan He. Targeting Metabolism: Innovative Therapies for MASLD Unveiled. International Journal of Molecular Sciences 2025; 26(9): 4077 doi: 10.3390/ijms26094077